Dr. Stripecke received her PhD in 1993 at the European Molecular Biology Laboratory and University of Heidelberg and her
Habilitation in 2002 at the University of Hamburg. She performed post-doctoral training at Childrens Hospital
Los Angeles. From 1999-2003 she was Assistant Professor at the University of Southern California (USC) in Los Angeles
and subsequently Assistant Professor at the University of California Los Angeles (UCLA), where she served as
Co-director of the UCLA Vector Core.
Dr. Stripecke joined the Hannover Medical School (MHH) in 2007 as Group Leader in the Program Area of Cell Therapy.
She was appointed as an Associate Professor in the Department of Hematology, Hemostasis, Oncology and Stem cell transplantation.
She is currently a member of REBIRTH, an excellence cluster research program dedicated to Regenerative Therapy.
Her Laboratory is funded by SFB738, a center grand focused on development of novel transplantation approaches.
Dr. Stripecke received her PhD in 1993 at the European Molecular Biology Laboratory and University of Heidelberg and her
Habilitation in 2002 at the University of Hamburg. She performed post-doctoral training at Childrens Hospital
Los Angeles. From 1999-2003 she was Assistant Professor at the University of Southern California (USC) in Los Angeles
and subsequently Assistant Professor at the University of California Los Angeles (UCLA), where she served as
Co-director of the UCLA Vector Core.
Dr. Stripecke joined the Hannover Medical School (MHH) in 2007 as Group Leader in the Program Area of Cell Therapy.
She was appointed as an Associate Professor in the Department of Hematology, Hemostasis, Oncology and Stem cell transplantation.
She is currently a member of REBIRTH, an excellence cluster research program dedicated to Regenerative Therapy.
Her Laboratory is funded by SFB738, a center grand focused on development of novel transplantation approaches.
dw-websites